NOK vs OCUL · P/E 87, $78.04B cap vs rev $24.3M
Nokia Corp ADR (NOK) versus Ocular Therapeutix Inc (OCUL) — a side-by-side from cached financials, not a winner call.
Nokia Corp ADR (NOK) is a communication equipment company listed on NYSE.
Ocular Therapeutix Inc (OCUL) is a biotechnology company listed on US.
NOK does not have a complete income-statement cache yet.
Latest reported OCUL revenue for 2026-06-30 was $24.3M. Net income was -$167.4M. OCUL currently screens at market cap $1.76B.
NOK currently screens at market cap $78.04B and trailing P/E 87.4. OCUL currently screens at market cap $1.76B.
Not investment advice. Open the NOK and OCUL stock pages for the full models.
Not investment advice.